Cellular and Molecular Imaging with SPECT and PET in Brain Tumors.
This review highlights the 2 major molecular imaging modalities that are used in clinics, namely single-photon emission computed tomography (SPECT) and positron emission tomography (PET), and their added value in management of patients with brain tumors. There are a variety of SPECT and PET radiotracers that can allow imaging of different molecular processes. Those radiotracers target specific molecular features of tumors, resulting in improved specificity of these agents. Potential applications include staging of brain tumors and evaluating post-therapeutic changes.
['Sadaghiani|Mohammad S|MS|', 'Sheikhbahaei|Sara|S|', 'Rowe|Steven P|SP|', 'Pomper|Martin G|MG|', 'Solnes|Lilja B|LB|']
D001921:Brain D001932:Brain Neoplasms D006801:Humans D057054:Molecular Imaging D049268:Positron-Emission Tomography D015899:Tomography, Emission-Computed, Single-Photon
Molecular imaging SPECT PET Brain tumor